December 25, 2014 11:05 AM ET

Biotechnology

Company Overview of VetDC, Inc.

Executive Profile

Terry J. Opgenorth Ph.D.

Chief Scientific Officer and Board Observer, VetDC, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 2 different industries.

See Board Relationships
----

Background

Dr. Terry J. Opgenorth, PhD serves as Chief Operating Officer of MicroRx and NeoTREX. Dr. Opgenorth serves as Chief Scientific Officer and Board Observer at VetDC, Inc. He serves as Scientific Advisor of Euroscreen S.A. He joined CSU Ventures, Inc. in 2007. He has a 20-year career as a Division Vice President in the Drug Discovery arm at Abbott Laboratories from 1987 to 2007. He is a Section Editor for Current Opinions in Investigational Drugs. He served as Divisional ...

Corporate Headquarters

320 East Vine Drive
Fort Collins, Colorado 80524

United States

Phone: 303-859-2072
Fax: --

Board Members Memberships

Director
Chief Scientific Officer and Board Observer

Education

MS
University of Illinois-Urbana-Champaign
PhD
University of Illinois-Urbana-Champaign
BA
Calvin College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VetDC, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.